Michael Wiederhorn
Stock Analyst at Oppenheimer
(3.61)
# 824
Out of 4,839 analysts
140
Total ratings
52.94%
Success rate
3.89%
Average return
Main Sectors:
Stocks Rated by Michael Wiederhorn
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| UNH UnitedHealth Group | Maintains: Outperform | $600 → $400 | $296.67 | +34.83% | 16 | May 14, 2025 | |
| HUM Humana | Maintains: Outperform | $300 → $310 | $227.14 | +36.48% | 13 | May 1, 2025 | |
| CI The Cigna Group | Maintains: Outperform | $400 → $375 | $312.68 | +19.93% | 11 | Jan 31, 2025 | |
| TDOC Teladoc Health | Maintains: Outperform | $14 → $12 | $6.90 | +73.91% | 11 | Jan 24, 2025 | |
| CNC Centene | Maintains: Outperform | $95 → $85 | $58.07 | +46.38% | 17 | Dec 13, 2024 | |
| PNTG The Pennant Group | Maintains: Outperform | $34 → $37 | $28.10 | +31.67% | 6 | Nov 8, 2024 | |
| HCA HCA Healthcare | Maintains: Outperform | $390 → $400 | $376.64 | +6.20% | 11 | Oct 28, 2024 | |
| ENSG The Ensign Group | Maintains: Outperform | $165 → $168 | $145.01 | +15.85% | 8 | Oct 25, 2024 | |
| ADUS Addus HomeCare | Maintains: Outperform | $140 → $145 | $111.84 | +29.65% | 10 | Sep 23, 2024 | |
| PACS PACS Group | Maintains: Outperform | $32 → $40 | $9.80 | +308.16% | 3 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $4.5 → $5 | $3.72 | +34.41% | 10 | Jul 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Perform | n/a | $10.26 | - | 2 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $625 → $650 | $561.44 | +15.77% | 12 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $175 → $145 | $93.68 | +54.78% | 10 | Oct 28, 2022 |
UnitedHealth Group
May 14, 2025
Maintains: Outperform
Price Target: $600 → $400
Current: $296.67
Upside: +34.83%
Humana
May 1, 2025
Maintains: Outperform
Price Target: $300 → $310
Current: $227.14
Upside: +36.48%
The Cigna Group
Jan 31, 2025
Maintains: Outperform
Price Target: $400 → $375
Current: $312.68
Upside: +19.93%
Teladoc Health
Jan 24, 2025
Maintains: Outperform
Price Target: $14 → $12
Current: $6.90
Upside: +73.91%
Centene
Dec 13, 2024
Maintains: Outperform
Price Target: $95 → $85
Current: $58.07
Upside: +46.38%
The Pennant Group
Nov 8, 2024
Maintains: Outperform
Price Target: $34 → $37
Current: $28.10
Upside: +31.67%
HCA Healthcare
Oct 28, 2024
Maintains: Outperform
Price Target: $390 → $400
Current: $376.64
Upside: +6.20%
The Ensign Group
Oct 25, 2024
Maintains: Outperform
Price Target: $165 → $168
Current: $145.01
Upside: +15.85%
Addus HomeCare
Sep 23, 2024
Maintains: Outperform
Price Target: $140 → $145
Current: $111.84
Upside: +29.65%
PACS Group
Aug 13, 2024
Maintains: Outperform
Price Target: $32 → $40
Current: $9.80
Upside: +308.16%
Jul 25, 2024
Maintains: Outperform
Price Target: $4.5 → $5
Current: $3.72
Upside: +34.41%
Mar 7, 2024
Maintains: Perform
Price Target: n/a
Current: $10.26
Upside: -
Feb 29, 2024
Maintains: Outperform
Price Target: $625 → $650
Current: $561.44
Upside: +15.77%
Oct 28, 2022
Maintains: Outperform
Price Target: $175 → $145
Current: $93.68
Upside: +54.78%